🇺🇸 FDA
Pipeline program

Pantoprazole

BY1023/UK-506

Approved small_molecule completed

Quick answer

Pantoprazole for Gastroesophageal Reflux is a Approved program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 3 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Gastroesophageal Reflux
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials